These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27659423)

  • 21. Macrophage ABCA2 deletion modulates intracellular cholesterol deposition, affects macrophage apoptosis, and decreases early atherosclerosis in LDL receptor knockout mice.
    Calpe-Berdiel L; Zhao Y; de Graauw M; Ye D; van Santbrink PJ; Mommaas AM; Foks A; Bot M; Meurs I; Kuiper J; Mack JT; Van Eck M; Tew KD; van Berkel TJ
    Atherosclerosis; 2012 Aug; 223(2):332-41. PubMed ID: 22748276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autophagy, lipophagy and lysosomal lipid storage disorders.
    Ward C; Martinez-Lopez N; Otten EG; Carroll B; Maetzel D; Singh R; Sarkar S; Korolchuk VI
    Biochim Biophys Acta; 2016 Apr; 1861(4):269-84. PubMed ID: 26778751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysosomal acid lipase and atherosclerosis.
    Du H; Grabowski GA
    Curr Opin Lipidol; 2004 Oct; 15(5):539-44. PubMed ID: 15361789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysosomal acid lipase deficiency: correction of lipid storage by adenovirus-mediated gene transfer in mice.
    Du H; Heur M; Witte DP; Ameis D; Grabowski GA
    Hum Gene Ther; 2002 Jul; 13(11):1361-72. PubMed ID: 12162818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholesteryl ester storage disease: a most unusual manifestation of deficiency of two lysosomal enzyme activities.
    Fredrickson DS; Sloan HR; Ferrans VJ; Demosky SJ
    Trans Assoc Am Physicians; 1972; 85():109-19. PubMed ID: 4660005
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug-induced intralysosomal storage of sulfated glycosaminoglycans (GAGs): a methodical pitfall occurring with acridine derivatives.
    Lüllmann-Rauch R
    Exp Toxicol Pathol; 1994 Oct; 46(4-5):315-22. PubMed ID: 7894242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of atherosclerotic plaques by lysosomal acid lipase supplementation.
    Du H; Schiavi S; Wan N; Levine M; Witte DP; Grabowski GA
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):147-54. PubMed ID: 14615393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A unique familial leukodystrophy with adult onset dementia and abnormal glycolipid storage: a new lysosomal disease?
    Simon DK; Rodriguez ML; Frosch MP; Quackenbush EJ; Feske SK; Natowicz MR
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):251-4. PubMed ID: 9703182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homozygous TBC1 domain-containing kinase (TBCK) mutation causes a novel lysosomal storage disease - a new type of neuronal ceroid lipofuscinosis (CLN15)?
    Beck-Wödl S; Harzer K; Sturm M; Buchert R; Rieß O; Mennel HD; Latta E; Pagenstecher A; Keber U
    Acta Neuropathol Commun; 2018 Dec; 6(1):145. PubMed ID: 30591081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caenorhabditis elegans as a model for lysosomal storage disorders.
    de Voer G; Peters D; Taschner PE
    Biochim Biophys Acta; 2008; 1782(7-8):433-46. PubMed ID: 18501720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lesions of an ovine lysosomal storage disease. Initial characterization.
    Murnane RD; Prieur DJ; Ahern-Rindell AJ; Parish SM; Collier LL
    Am J Pathol; 1989 Feb; 134(2):263-70. PubMed ID: 2916646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of lpd (lipid defect): a novel mutation on mouse chromosome 16 associated with a defect in triglyceride metabolism.
    Wen XY; Bryce DM; Breitman ML
    Hum Mol Genet; 1998 Apr; 7(4):743-50. PubMed ID: 9499429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial Dysfunction and Neurodegeneration in Lysosomal Storage Disorders.
    Plotegher N; Duchen MR
    Trends Mol Med; 2017 Feb; 23(2):116-134. PubMed ID: 28111024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The storage lipids in Tangier disease. A physical chemical study.
    Katz SS; Small DM; Brook JG; Lees RS
    J Clin Invest; 1977 Jun; 59(6):1045-54. PubMed ID: 193870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of
    Sellin J; Schulze H; Paradis M; Gosejacob D; Papan C; Shevchenko A; Psathaki OE; Paululat A; Thielisch M; Sandhoff K; Hoch M
    Dis Model Mech; 2017 Jun; 10(6):737-750. PubMed ID: 28389479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Storage problems in lysosomal diseases.
    Heard JM; Bruyère J; Roy E; Bigou S; Ausseil J; Vitry S
    Biochem Soc Trans; 2010 Dec; 38(6):1442-7. PubMed ID: 21118104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lysosomal-storage disorder induced by elmiron following 90-days gavage administration in rats and mice.
    Nyska A; Nold JB; Johnson JD; Abdo K
    Toxicol Pathol; 2002; 30(2):178-87. PubMed ID: 11950161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of advanced disease in lysosomal acid lipase deficient mice: a model for lysosomal acid lipase deficiency disease.
    Sun Y; Xu YH; Du H; Quinn B; Liou B; Stanton L; Inskeep V; Ran H; Jakubowitz P; Grilliot N; Grabowski GA
    Mol Genet Metab; 2014 Jul; 112(3):229-41. PubMed ID: 24837159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of oxLDL uptake leads to decreased atherosclerosis in hematopoietic NPC1-deficient Ldlr
    Jeurissen MLJ; Walenbergh SMA; Houben T; Gijbels MJJ; Li J; Hendrikx T; Oligschlaeger Y; van Gorp PJ; Binder CJ; Donners MMPC; Shiri-Sverdlov R
    Atherosclerosis; 2016 Dec; 255():59-65. PubMed ID: 27816810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.